Feigal, Tunis To Present At HHS Reg Reform Panel On FDA/CMS Partnerships
This article was originally published in The Gray Sheet
Executive Summary
Collaborative opportunities between FDA and the Centers for Medicare & Medicare Services for approving new technologies will be explored during the upcoming 1HHS Advisory Committee on Regulatory Reform's public hearing in Minneapolis